A systems approach to prefrontal-limbic dysregulation in schizophrenia

Neuropsychobiology

Volumn 57, Issue 4, 2008, Pages 206-216

  Rǎdulescu, Anca R ^a   Mujica Parodi, L R ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b St Francis Hospital The Heart Center   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Amygdala; Cross correlation; Dynamic control system; Dysregulation, limbic, prefrontal; Functional magnetic resonance imaging; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; BENZATROPINE; CLOZAPINE; DULOXETINE; FLUPHENAZINE; LORAZEPAM; PERPHENAZINE; RISPERIDONE; SERTRALINE; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE;

ADULT; AMYGDALOID NUCLEUS; AROUSAL; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FACIAL EXPRESSION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LIMBIC CORTEX; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AROUSAL; BRAIN MAPPING; CASE-CONTROL STUDIES; EMOTIONS; FEMALE; HUMANS; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MODELS, NEUROLOGICAL; NEURAL PATHWAYS; PREFRONTAL CORTEX; REFERENCE VALUES; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC; SYSTEMS BIOLOGY; SYSTEMS THEORY; YOUNG ADULT;

EID: 50249182303     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151731     Document Type: Article

References (98)

1. Bachrach LL: Chronicity in schizophrenia. Hosp Community Psychiatry 2000;38:1226-1227.
2. Ashe PC, Berry MD, Boulton AA: Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:691-707.
3. Malaspina D: Schizophrenia: a neurodevelopmental or a neurodegenerative disorder. J Clin Psychiatry 2006;67:e07.
4. Ananth H, Popescu I, Critchley HD, Good CD, Frackowiak R, Dolan RJ: Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am J Psychiatry 2002;159:1497-1505.
5. Lawrie SM, Whalley HC, Job DE, Johnstone EC: Structural and functional abnormalities of the amygdala in schizophrenia. Ann NY Acad Sci 2003;985:445-460.
6. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), ed 4. Washington, APA, 1994.
7. McGlashan TH: Early detection and intervention of schizophrenia: rationale and research. Br J Psychiatry Suppl 1998;172:3-6.
8. Kay SR, Opler LA, Lindenmayer JP: The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry Suppl 1989;7:59-67.
9. Corcoran C, Mujica-Parodi L, Yale S, Leitman D, Malaspina D: Could stress cause psychosis in individuals vulnerable to schizophrenia? CNS Spectr, 2002;7:33-38, 41-42.
10. Kernohan AFB, Perry CG, Small M: Clinical impact of the new criteria for the diagnosis of diabetes mellitus. Clin Chem Lab Med 2003:41:1239-1245.
11. Reimondo G, Paccotti P, Minetto M, Termine A, Stura G, Bergui M, Angeli A, Terzolo M: The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome. Clin Endocrinol 2003;58:718-724.
12. Williams LM, Harris AWF, Liddell BB, Olivieri G, Phillips ML, Peduto A, Gordon E: Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry 2004;161:480-489.
13. Ritsner M, Maayan R, Gibel A, Strous RD, Modai I, et al: Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. Eur Neuropsychopharmacol 2004;14:267-273.
14. Tandon R, Mazzara C, DeQuardo J, Craig KA, Meador-Woodruff JH, Goldman R, et al: Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome. Biol Psychiatry 1991;29:953-964.
15. Dawson ME, Nuechterlein KH, Schell AM, Gitlin M, Ventura J: Autonomic abnormalities in schizophrenia: state or trait indicators? Arch Gen Psychiatry 1994;51:813-824.
16. Mujica-Parodi LR, Yeregani V, Malaspina D: Nonlinear complexity and spectral analyses of heart rate variability in medicated and unmedicated patients with schizophrenia. Neuropsychobiology 2005;51:10-15.
17. 3 receptor agonists and therapeutic agents. Drug Discov Today 2005;10:917-925.
18. Yamamoto K, Hornykiewich O: Proposal for a noradrenaline hypothesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:913-922.
19. Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, et al: Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 2002;159:1018-1028.
20. Kapur S, Mamo D: Half a century of antipsychotics and still a central role for dopamine D 2 receptors. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:1081-1090.
21. Finlay JM, Zigmond MJ: The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochem Res 1997;22:1387-1394.
22. Jackson ME, Moghaddam B: Stimulus-specific plasticity of prefrontal cortex dopamine neurotransmission. J Neurochem 2004;88:1327-1334.
23. Moghaddam B, Jackson M: Effect of stress on prefrontal cortex function. Neurotox Res 2004;6:73-78.
24. Gruzelier JH, Lykken DT, Venables PH: Schizophrenia and arousal revisited: two-flash thresholds and electrodermal activity in activated and nonactivated conditions. Arch Gen Psychiatry 1972;26:427-432.
25. Gruzelier JH: Clinical attributes of schizophrenic skin conductance responders and non-responders. Psychol Med 1976;6:245-249.
26. Dawson ME, Nuechterlein KH, Schell AM, Mintz J: Concurrent and predictive electrodermal correlates of symptomatology in recent-onset schizophrenic patients. J Abnorm Psychol 1992;101:153-164.
27. Dawson ME, Nuechterlein KH, Schell AM: Electrodermal anomalies in recent-onset schizophrenia: relationships to symptoms and prognosis. Schizophr Bull 1992;18:295-311.
28. Nuechterlein KH, Dawson ME, Gitlin M, et al: Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophr Bull 1992;18:387-425.
29. Corcoran C, Gallitano A, Leitman D, Malaspina D: The neurobiology of the stress cascade and its potential relevance for schizophrenia. J Psychiatr Pract 2001;7:3-14.
30. Grossberg S: The imbalanced brain: from normal behavior to schizophrenia. Biol Psychiatry 2000;48:81-98.
31. Hanlon FM, Sutherland RJ: Changes in adult brain and behavior caused by neonatal limbic damage: implications for the etiology of schizophrenia. Behav Brain Res 2000;107:71-83.
32. McEwen BS: Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann NY Acad Sci 2004;1032:1-7.
33. Mujica-Parodi LR: Are cognitive symptoms of schizophrenia mediated by abnormalities in emotional arousal? CNS Spectr 2002;7:58-60, 65-69.
34. Gulpinar MA, Yegen BC: The physiology of learning and memory: role of peptides and stress. Curr Protein Pept Sci 2004;5:457-473.
35. Pavlides CN, Nivon LG, McEwen BS: Effects of chronic stress on hippocampal long-term potentiation. Hippocampus 2002;12:245-257.
36. Braff DL, Light GA: Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology 2004;174:75-85.
37. Mathalon DH, Heinks T, Ford JM: Selective attention in schizophrenia: sparing and loss of executive control. Am J Psychiatry 2004;161:872-881.
38. Hirsch S, Weinberger D: Schizophrenia, ed 1. Oxford, Blackwell, 1995.
39. Brugger P, Regard M, Landis T, Oelz O: Hallucinatory experiences in extreme-altitude climbers. Neuropsychiatry Neuropsychol Behav Neurol 1999;12:67-71.
40. Ghisolfi ES, Schuch A, Strimitzer IM Jr, Luersen G, Martins FF, Ramos F, Becker J, Lara DR: Caffeine modulates P50 auditory sensory gating in healthy subjects. Eur Neuropsychopharmacol 2006;16:204-210.
41. Silva JA, Leong GB, Harry BE, Ronan J, Weinstock R: Dangerous misidentification of people due to flashback phenomena in posttraumatic stress disorder. J Forensic Sci 1998;43:1107-1111.
42. Russell TA, Reynaud E, Kucharska-Pietura K, Ecker C, Benson PJ, Zelaya F, Giampietro V, Brammer M, David A, Phillips ML: Neural responses to dynamic expressions of fear in schizophrenia. Neuropsychologia 2007;45:107-123.
43. Holt DJ, Kunkel L, Weiss AP, Goff DC, Wright CI, Shin LM, Rauch SL, Hootnick J, Heckers S: Increased medial temporal lobe activation during the passive viewing of emotional and neutral facial expressions in schizophrenia. Schizophr Res 2006;82:153-162.
44. Williams LM, Das P, Liddell BJ, Olivieri G, Peduto AS, David AS, Gordon E, Harris AW: Fronto-limbic and autonomic disjunctions to negative emotion distinguish schizophrenia subtypes. Psychiatry Res 2007;155:19-44.
45. Tamminga CA: The neurobiology of cognition in schizophrenia. J Clin Psychiatry 2006;67(suppl 9):9-13, discussion 36-42.
46. Hazlett H, Dawson ME, Schell AM, Nuechterlein KH: Electrodermal activity as a prodromal sign in schizophrenia. Biol Psychiatry 1997;41:111-113.
47. Sapolsky RM, Plotsky PM: Hypercortisolism and its possible neural bases. Biol Psychiatry 1990;27:937-952.
48. Weinberger D, McClure R: Neurotoxicity, neuroplasticity and magnetic resonance imaging morphometry. Arch Gen Psychiatry 2002;59:553-558.
49. Kessler RC, Amminger G, Aguilar-Gaxiola S, Alonso J, Lee S, Ustn T: Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry 2007;20:359-364.
50. Grant MM, Friedman ES, Haskett RF, Riso LP, Thase ME: Urinary free cortisol levels among depressed men and women: differential relationships to age and symptoms severity? Arch Womens Ment Health 2007;10:73-78.
51. Batzel JJ, Kappel F, Timischl-Teschl S: A cardiovascular-respiratory control system model including state delay with application to congestive heart failure in humans. J Math Biol 2005;50:293-335.
52. Shibata T, Tabata H, Schaal S, Kawato M: A model of smooth pursuit in primates based on learning the target dynamics. Neural Netw 2005;18:213-224.
53. LeDoux JE: Emotion circuits in the brain. Annu Rev Neurosci 2000;23:155-184.
54. Maren S: Building and burying fear memories in the brain. Neuroscientist 2005;11:89-99.
55. Adolphs R, Tranel D, Hamann S, Young A, Calder A, Anderson A, Phelps E, Damasio AR: Recognition of facial emotion in nine individuals with bilateral amygdala damage. Neuropsychologia 1999;37:1111-1117.
56. Schwerdtner J, Sommer M, Weber T, Muller J: Functional neuroanatomy of emotions. Psychiatr Prax 2004;31(suppl 1):S66-S77.
57. Whalen PJ: Fear, vigilance and ambiguity: initial neuroimaging studies of the human amygdala. Curr Dir Psychol Sci 1998;7:177-188.
58. Shin LM, Wright CI, Cannistraro PA, Wedig M, McMullin K, Martis B, et al: A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry 2005;62:273-281.
59. Corcoran KA: Hippocampal inactivation disrupts the acquisition and contextual encoding of fear extinction. J Neurosci 2005;25:8978-8987.
60. Sotres-Bayon F, Bush D, LeDoux J: Emotional perseveration: an update on prefrontal-amygdala interactions in fear extinction. Learn Mem 2004;11:525-535.
61. Rykhlevskaia E, Gratton G, Fabiani M: Combining structural and functional neuroimaging data for studying brain connectivity: a review. Psychophysiology 2008;45:173-187.
62. Ekman P, Friesen WV: Pictures of Facial Affect. Palo Alto, Consulting Psychologists Press, 1976.
63. Morris JS, Friston KJ, Buchel C, Frith CD, Young AW, Calder AJ, Dolan RJ: A neuromodulatory role for the human amygdala in processing emotional facial expressions. Brain 1998;121:47-57.
64. Phillips ML, Young AW, Senior C, Brammer M, Andrew C, Calder AJ, Bullmore ET, Perrett DI, Rowland D, Williams S, Gray JA, David AS: A specific neural substrate for perceiving facial expressions of disgust. Nature 1997;389:495-498.
65. Nagin DS: Analyzing developmental trajectories: a semiparametric, group-based approach. Psychol Methods 1999;4:139-157.
66. Haviland AM, Nagin DS: Causal inferences with group based trajectory models. Psychometrika 2005;70:1-22.
67. Ventura J, Liberman RP, Green MF, Shaner A, Mintz J: Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res 1998;79:163-173.
68. Friston K, Ashburner J, Heather J, et al: Statistical parametric mapping. Available at: www.fil.ion.ucl.ac.uk/spm. The Wellcome Department of Cognitive Neurology, University College London, London, 1999.
69. Hastings RS, Pa V, Oquendo MA, Arango V, Mann JJ: Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology 2004;29:952-959.
70. Sotres-Bayon F, Cain CK, LeDoux JE: Brain mechanisms of fear exinction: historical perspectives on the contribution of prefrontal cortex. Learn Mem 2006;11:525-535.
71. Namiki C, Hirao K, Yamada M, Hanakawa T, Fukuyama H, Hayashi T, Murai T: Impaired facial emotion recognition and reduced amygdalar volume in schizophrenia. Psychiatry Res 2007;156:23-32.
72. Johnston PJ, Stojanov W, Devir H, Schall U: Functional MRI of facial emotion recognition deficits in schizophrenia and their electrophysiological correlates. Eur J Neurosci 2005;22:1221-1232.
73. Takahashi H, Koeda M, Oda K, Matsuda T, Matsushima E, Matsuura M, Asai K, Okubo Y: An fMRI study of differential neural response to affective pictures in schizophrenia. Neuroimage 2004;22:1247-1254.
74. Das P, Kemp AH, Flynn G, Harris AW, Liddell BJ, Whitford TJ, Peduto A, Gordon E, Williams LM: Functional disconnections in the direct and indirect amygdala pathways for fear processing in schizophrenia. Schizophr Res 2007;90:284-294.
75. Aleman A, Kahn RS: Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol 2005;77:283-298.
76. Holt D, Titone D, Long L, Goff D, Cather C, Rauch S, Judge A, Kuperberg G: The misattribution of salience in delusional patients with schizophrenia. Schizophr Res 2006;83:247-256.
77. Gur RE, McGrath C, Chan RM, Schroeder L, Turner T, Turetsky BI, Kohler C, Alsop D, Maldijan J, Ragland JD, Gur RC: An fMRI study of facial emotion processing in patients with schizophrenia. Am J Psychiatry 2002;159:1992-1999.
78. Kosaka H, Omori M, Murata T, Iidaka T, Yamada H, Okada T, Takahashi T, Sadoto N, Itoh H, Yonekura Y, Wada Y: Differential amygdala response during facial recognition in patients with schizophrenia: an fMRI study. Schizophr Res 2002;57:87-95.
79. Hempel A, Hempel E, Schonknecht P, Stippich C, Schroder J: Impairment in basal limbic function in schizophrenia during affect recognition. Psychiatry Res 2003;122:115-124.
80. Fahim C, Stip E, Mancini-Marïe A, Mensour B, Boulay LJ, Leroux JM, Beaudoin G, Bourgouin P, Beauregard M: Brain activity during emotionally negative pictures in schizophrenia with and without flat affect - an fMRI study. Psychiatry Res 2005;140:1-15.
81. Williams LM, Das P, Harris AW, Liddell BB, Brammer MJ, Olivieri G, Skerrett D, Phillips ML, David AS, Perduto A, Gordon E: Frontolimbic and autonomic disjunctions to negative emotion distinguish schizophrenia subtypes. Am J Psychiatry 2004;161:480-489.
82. Mujica-Parodi LR, Korgaonkar M, Ravindranath B, Greenberg T, Tomasi D, Wagshul M, Ardekani B, Guilfoyle D, Khan S, Zhong Y, Chon K, Malaspina D: Limbic dysregulation is associated with lowered heart rate variability and increased trait anxiety in healthy adults. Human Brain Mapp 2007, E-pub ahead of print.
83. Kim H, Somerville LH, Johnstone T, Alexander AL, Whalen PJ: Inverse amygdala and medial prefrontal cortex responses to surprised faces. Neuroreport 2003;14:2317-2322.
84. Schienle A, Schafer A, Walter B, Stark R, Vaitl D: Brain activations of spider phobics towards disorder-relevant, generally disgust- and fear-including pictures, Neurosci Lett 2005;388:1-6.
85. Hoptman MJ, Volavka J, Weiss EM, Czobor P, Szeszko PR, Gerig G, et al: Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder. Psychiatry Res 2005;140:133-145.
86. Hariri AR, Bookheimer SY, Mazziotta JC: Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport 2000;11:43-48.
87. Hariri AR, Mattay VS, Tessitore A, Fera F, Weinberger DR: Neurocortical modulation of the amygdala response to fearful stimuli. Biol Psychiatry 2003;53:494-501.
88. Krain AL, Wilson AM, Arbuckle R, Castellanos FX, Milham MP: Distinct neural mechanisms of risk and ambiguity: a meta-analysis of decision-making. Neuroimage 2006;31:477-484.
89. Mogg A, Purvis R, Eranti S, Contell F, et al: Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study. Schizophr Res 2007;93:221-228.
90. Osaka N, Otsuka Y, Hirose N, Ikeda T, Mima T, Fukuyama H, Osaka M: Transcranial magnetic stimulation (TMS) applied to left dorsolateral prefrontal cortex disrupts verbal working memory performance in humans. Neurosci Lett 2007;418:232-235.
91. Raust A, Slama F, Mathieu F, Roy I, et al: Prefrontal cortex dysfunction in patients with suicidal behavior. Psychol Med 2007;37:411-419.
92. Weiss EM, Siedentopf C, Golaszewski S, Mottaghy FM, et al: Brain activation patterns during a selective attention test - a functional MRI study in healthy volunteers and unmedicated patients during an acute episode of schizophrenia. Psychiatry Res 2007;154:31-40.
93. Pinkham AE, Penn DL, Perkins DO, Lieberman J, et al: Implications for the neural basis of social cognition for the study of schizophrenia, Am J Psychiatry 2003;160:815-824.
94. Faure P, Korn H: Is there chaos in the brain? I. Concepts of nonlinear dynamics and methods of investigation. C R Acad Sci III 2001;324:773-793.
95. Davis M, Whalen PJ: The amygdala: vigilance and emotion. Mol Psychiatry 2001;6:13-34.
96. Izquierdo A, Suda RK, Murray EA: Comparison of the effects of bilateral orbital prefrontal cortex lesions and amygdala lesions on emotional responses in rhesus monkeys. J Neurosci 2005;25:8534-8542.
97. Phelps EA, Delgado M, Nearing K, LeDoux J: Extinction learning in humans: role of the amygdala and vmPFC. Neuron 2004;43:897-905.
98. Rosenkranz JA, Moore H, Grace AA: The prefrontal cortex regulates lateral amygdale neuronal plasticity and responses to previously conditioned stimuli. J Neurosci 2003;23:11054-11064.